MDS-PAS Congress 2026 Session Evaluation

MDS-PAS Congress 2026 Session 2103 Evaluation Form
Plenary Session 2103

Ataxia Therapies: What Works, What's New, and What's Next?

February 14, 2026

08:00 - 09:45
Learning Objectives:

1. Analyze effective symptomatic and supportive therapies currently used in ataxia management
2. Recognize the landscape of emerging treatments for ataxia through late-stage clinical trials
3. Discuss upcoming innovative gene therapy approaches and future technologies in the development of therapies for ataxia
Session Evaluation
The session met its learning objectives

Strongly agreeAgreeDisagreeStrongly disagree
The content is relevant to my professional and / or scientific interests.

Strongly agreeAgreeDisagreeStrongly disagree
The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.

Strongly agreeAgreeDisagreeStrongly disagree
The overall session organization was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
I would recommend this session to a colleague.

Strongly agreeAgreeDisagreeStrongly disagree
Faculty Assessment
José Luiz Pedroso
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Sergio Rodriguez Quiroga
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Christopher Stephen
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
How would you improve this activity?
Please provide any additional comments
The following category best describes your current major professional activity (choose one):

Patient managementBasic Science researchClinical ResearchTeachingResident/PhD StudentUndergraduate StudentOther
My country:
Should be Empty:

MDS-PAS Congress 2026 Session 2103 Evaluation Form

Plenary Session 2103

Ataxia Therapies: What Works, What's New, and What's Next?